AstraZeneca rises after report on U.S. listing plans AstraZeneca rises after report on U.S. listing plans Post ContentaznRead More You might also be interested in reading investingLive Launches 2026 Broker & Prop Firm Comparisons. July 1, 2025 In Mainstream ← Previous post Next post →